Capacity building for oncology programmes in sub-Saharan Africa: the Rwanda experience

Stulac, Sara; Binagwaho, Agnès; Tapela, Neo; Wagner, Claire; Muhimpundu, Marie Aimée; Ngabo, Fidèle; Nsanzimana, Sabin; Kayonde, Leonard; Bigirimana, Jean Bosco; Lessard, Adam J; Lehmann, Leslie; Shulman, Lawrence N.; Nutt, Cameron T; Drobac, Peter; Mpunga, Tharcisse; Farmer, Paul

doi:10.1016/s1470-2045(15)00161-8

Cited by 63 publications

(70 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Chemotherapy and endocrine therapy can be essential for reducing the risk for recurrence and improving survival. Taskshifting models that use nurses, clinical officers, and general practitioners in close partnership with remotely or locally based oncologists show early promise in facilitating cancer care in remote areas and are being used and examined in settings such as Rwanda and Kenya [34][35][36].…”

Section: Treatment Of Breast Cancer In Lmicsmentioning

confidence: 99%

“…Although endocrine therapies, such as tamoxifen, are often available at low prices, targeted therapies such as trastuzumab remain prohibitively expensive in most low-resource settings. The cost of chemotherapy highlights the need for strategic procurement of affordable chemotherapy and development of context-specific treatment protocols that optimize safety and effectiveness while minimizing costs [34].…”

Section: Treatment Of Breast Cancer In Lmicsmentioning

confidence: 99%

See 1 more Smart Citation

Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality

2016

View full text Add to dashboard Cite

The objective of this review is to describe existing data on breast cancer incidence and mortality in low-and middleincome countries (LMICs), in particular in sub-Saharan Africa; identify the limitations of these data; and review what is known about breast cancer control strategies in sub-Saharan African countries and other LMICs. Available estimates demonstrate that breast cancer incidence and mortality are rising in LMICs, including in Africa, although high-quality data from LMICs (and particularly from sub-Saharan Africa) are largely lacking. Case fatality rates from breast cancer appear to be substantially higher in LMICs than in high-income countries. Significant challenges exist to developing breast cancer control programs in LMICs, perhaps particularly in sub-Saharan Africa, and the most effective strategies for treatment and early detection in the context of limited resources are uncertain. High-quality research on breast cancer incidence and mortality and implementation research to guide effective breast cancer control strategies in LMICs are urgently needed. Enhanced investment in breast cancer research andtreatment in LMICs should be a global public health priority. The Oncologist 2016;21:739-744Implications for Practice: The numbers of new cases of breast cancer, and breast cancer deaths per year, in low-and middle-income countries are rising. Engagement by the international breast cancer community is critical to reduce global disparities in breast cancer outcomes. Cancer specialists and institutions in high-income countries can serve as key partners in training initiatives, clinical care, protocol and program development, and research. This article provides an overview of what is known about breast cancer incidence, mortality, and effective strategies for breast cancer control in sub-Saharan Africa and identifies key gaps in the literature. This information can help guide priorities for engagement by the global cancer community.

show abstract

Section: Treatment Of Breast Cancer In Lmicsmentioning

confidence: 99%

Section: Treatment Of Breast Cancer In Lmicsmentioning

confidence: 99%

Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality

2016

View full text Add to dashboard Cite

show abstract

“…This highly successful program was possible, the authors note, because of the integration of cancer care within an existing and effective community-based ART program [42]. From the provision of care for chronic conditions diseases to the identification, treatment, and follow-up of patients with cancer [43–45], PIH’s community-based, health center-enriched, and hospital-linked delivery systems have enabled an effective response to both the burden of disease afflicting the poor and the gaps encountered in their care, while serving as platforms for training thousands of professionals and generating new knowledge to alleviate suffering caused by disease.…”

Section: Community-based Art As a Platform For Care Delivery Toward Umentioning

confidence: 99%

Community-Based ART Programs: Sustaining Adherence and Follow-up

et al. 2016

View full text Add to dashboard Cite

The advent of antiretroviral therapy (ART) in 1996 brought with it an urgent need to develop models of health care delivery that could enable its effective and equitable delivery, especially to patients living in poverty. Community-based care, which stretches from patient homes and communities—where chronic infectious diseases are often best managed—to modern health centers and hospitals, offers such a model, providing access to proximate HIV care and minimizing structural barriers to retention. We first review the recent literature on community-based ART programs in low- and low-to-middle-income country settings and document two key principles that guide effective programs: decentralization of ART services and long-term retention of patients in care. We then discuss the evolution of the community-based programs of Partners In Health (PIH), a nongovernmental organization committed to providing a preferential option for the poor in health care, in Haiti and several countries in sub-Saharan Africa, Latin America, Russia and Kazakhstan. As one of the first organizations to treat patients with HIV in low-income settings and a pioneer of the community-based approach to ART delivery, PIH has achieved both decentralization and excellent retention through the application of an accompaniment model that engages community health workers in the delivery of medicines, the provision of social support and education, and the linkage between communities and clinics. We conclude by showing how PIH has leveraged its HIV care delivery platforms to simultaneously strengthen health systems and address the broader burden of disease in the places in which it works.

show abstract

“…A surgeon may be needed to provide any combination of diagnostic or staging biopsies, curative resection, or palliative operations in the care of patients . Efforts are ongoing to foster research, education, and advocacy to increase awareness of cancer in sub‐Saharan Africa (SSA) and other LMICs more broadly . Despite this, the burden of cancer in SSA remains poorly described and accurate data on the occurrence and treatment of cancer and surgical outcomes remain insufficient …”

Section: Introductionmentioning

confidence: 99%

Surgical oncology at a major referral center in Ghana: Burden, staging, and outcomes

Gyedu

Gaskill

Agbedinu

et al. 2018

Journal of Surgical Oncology

View full text Add to dashboard Cite

show abstract

Capacity building for oncology programmes in sub-Saharan Africa: the Rwanda experience

Cited by 63 publications

References 41 publications

Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality

Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality

Community-Based ART Programs: Sustaining Adherence and Follow-up

Surgical oncology at a major referral center in Ghana: Burden, staging, and outcomes

Contact Info

Product

Resources

About